DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Fasching PA, Blohmer JU, Burchardi N. et al.
A randomized phase II trial to assess the efficacy of paclitaxel and olaparib in comparison to paclitaxel/carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant chemotherapy in patients with HER2-negative early breast cancer and homologous recombination deficiency (HRD): GeparOLA.
J Clin Oncol 2016;
34 (Suppl.) Abstr.. TPS1096
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.